Management paradigms for metastatic castration-sensitive prostate cancer
How does the clinician use quality of life data to decide between chemotherapy and hormonal therapy?
Date
16 Oct 2020Session
Management paradigms for metastatic castration-sensitive prostate cancerPresenters
Alicia MorgansAuthors
A.K. MorgansAuthor affiliations
- Medicine, Northwestern University Feinberg School of Medicine, 60611 - Chicago/US
Resources
Resources from the same session
Treatment of the primary in metastatic prostate patients
Presenter: Bertrand Tombal
Session: Management paradigms for metastatic castration-sensitive prostate cancer
Resources:
Slides
Webcast
Current and future systemic treatments of mCSPC
Presenter: Karim Fizazi
Session: Management paradigms for metastatic castration-sensitive prostate cancer
Resources:
Slides
Webcast
Genetic counselling for patients diagnosed with metastatic disease
Presenter: Elena Castro Marcos
Session: Management paradigms for metastatic castration-sensitive prostate cancer
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Karim Fizazi
Session: Management paradigms for metastatic castration-sensitive prostate cancer
Resources:
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.